re: Treatment for infant muscle wasting disease to hit market. potential price: $2 million

The price of a new drug has to cover research and development, then additional rounds of testing for the FDA approval, then production cost. There’s a lot that goes into it. Then the company tries to make some money. If the company is making an average margin on this drug, then the price is acceptable. If the company is gouging, then frick them. But gene therapy studies are incredibly expensive and time consuming. The research on this drug could easily be 10 years in the making. 10 years of paying for a lab, expensive research, multiple doctors and chemists that are experts in their fields, plus overhead. That’s a lot of costs. That one drug has to recoup a lot of value